Ligand profile
10D
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: HT085_RS00375 — 4-hydroxy-3-methylbut-2-enyl diphosphate reductase
Identifiers
Database identifiers and provenance.
- Ligand ID
10D- PDB
4h4c- UniProt (similar protein)
P62623- Target protein
- HT085_RS00375
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 113.3
- −1 ≤ LogP ≤ 5 1.13
- MW ≤ 500 Da 264.1
- LogP ≤ 5 1.13
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 6
- TPSA ≤ 140 Ų 113.3
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C/C(=C\COP(=O)(O)OP(=O)(O)O)/CFC/C(=C\COP(=O)(O)OP(=O)(O)O)/CF
InChI=1S/C5H11FO7P2/c1-5(4-6)2-3-12-15(10,11)13-14(7,8)9/h2H,3-4H2,1H3,(H,10,11)(H2,7,8,9)/b5-2+InChI=1S/C5H11FO7P2/c1-5(4-6)2-3-12-15(10,11)13-14(7,8)9/h2H,3-4H2,1H3,(H,10,11)(H2,7,8,9)/b5-2+
OAODEACEICJXDG-GORDUTHDSA-NOAODEACEICJXDG-GORDUTHDSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF02401
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand 10D →
- PDB RCSB structure 4h4c →
- UniProt UniProt P62623 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “10D”) →
Other ligands for this protein
Quick navigation to other ligands bound to HT085_RS00375.
PDB 16
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 1
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 12
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).